Cargando…

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment

Detalles Bibliográficos
Autores principales: Pardo-Cabello, Alfredo Jose, Manzano-Gamero, Victoria, Belda-Rustarazo, Susana, Giner-Escobar, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847534/
https://www.ncbi.nlm.nih.gov/pubmed/33517559
http://dx.doi.org/10.1007/s11739-021-02645-8
_version_ 1783644941479575552
author Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Belda-Rustarazo, Susana
Giner-Escobar, Pilar
author_facet Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Belda-Rustarazo, Susana
Giner-Escobar, Pilar
author_sort Pardo-Cabello, Alfredo Jose
collection PubMed
description
format Online
Article
Text
id pubmed-7847534
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78475342021-02-01 Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Belda-Rustarazo, Susana Giner-Escobar, Pilar Intern Emerg Med Ce - Letter to the Editor Springer International Publishing 2021-01-31 2021 /pmc/articles/PMC7847534/ /pubmed/33517559 http://dx.doi.org/10.1007/s11739-021-02645-8 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Ce - Letter to the Editor
Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Belda-Rustarazo, Susana
Giner-Escobar, Pilar
Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title_full Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title_fullStr Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title_full_unstemmed Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title_short Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
title_sort adverse drug reactions in sars-cov-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
topic Ce - Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847534/
https://www.ncbi.nlm.nih.gov/pubmed/33517559
http://dx.doi.org/10.1007/s11739-021-02645-8
work_keys_str_mv AT pardocabelloalfredojose adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment
AT manzanogamerovictoria adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment
AT beldarustarazosusana adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment
AT ginerescobarpilar adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionscomment